A study was conducted to evaluate the effectiveness of diode laser (DL) (Biolase EpicTM, 940 nm, Irvine, CA, USA) as an adjunct to scaling root and planing (SRP) on periodontal health and glycated hemoglobin (HbA1c) level of type 2 diabetes mellitus (T2DM) patients suffering from generalized chronic periodontitis, currently, stage II or above/grade B or C periodontitis.
Type 2 diabetes mellitus (T2DM) is a complex, chronic endocrinal ailment of metabolic derangement in carbohydrate, protein, and fat metabolism caused by resistance to insulin action or increased compensatory insulin secretory response, or a combination of both. It is predicted that there are already 415 million adults aged between 20 and 79 years suffering from diabetes worldwide, including 193 million who are undiagnosed. T2DM has a deep effect on mankind health and needs continuous multidisciplinary management strategies. Periodontal disease has been recognized as a possible modifiable risk factor for poorly controlled DM patients. There are substantial evidence based on observational and few randomized clinical trials that establish a bidirectional relationship between diabetes and periodontitis events. The presence of one condition tends to promote the other, and the meticulous management of either may assist treatment of the other. Current literature of various meta-analysis advocated that periodontal treatment might be effective in improving metabolic control in terms of reduction of HbA1c concentration in diabetic patients.